News: Bavarian Nordic A/S (BAVA.CO)

BAVA.CO on Copenhagen Stock Exchange

161.50DKK
10:26am EST
Price Change (% chg)

kr.0.50 (+0.31%)
Prev Close
kr.161.00
Open
kr.164.00
Day's High
kr.164.00
Day's Low
kr.159.00
Volume
10,943
Avg. Vol
13,973
52-wk High
kr.291.50
52-wk Low
kr.100.50

view news for:
Select another date:

Tue, Dec 1 2009

Bavarian Nordic plans $50-60 mln rights issue

COPENHAGEN, Dec 1 (Reuters) - Danish biotech firm Bavarian Nordic A/S aims to raise up to 300 million crowns ($60.62 million) by issuing stock to existing shareholders to develop and market new drugs, it said on Tuesday.

Bavarian Nordic eyes Canada mkt for smallpox drug

COPENHAGEN, Nov 30 (Reuters) - Danish biotechnology firm Bavarian Nordic aims to seek approval next year to sell its smallpox vaccine Imvamune in Canada, which would be its first market, the company said on Monday.

STOCKS NEWS EUROPE-Biotech Bavarian Nordic down on capital need

Danish biotech company Bavarian Nordic falls 9.1 percent, distinctly underperforming peers in the MSCI European pharma, biotech and life sciences index , with analysts citing the company's tentative plans to seek to raise new capital.

UPDATE 1-Bavarian to file new claim vs Oxford Biomedica

COPENHAGEN, Jan 12 (Reuters) - Denmark's Bavarian Nordic said on Monday it would file a new patent infringement complaint in its suit against Britain's Oxford BioMedica after a United States judge dismissed the first allegation.

European biotech hurting but lucky few to win big

By Ben Hirschler, European Pharmaceuticals Correspondent - Analysis

European biotech hurting but lucky few to win big

By Ben Hirschler, European Pharmaceuticals Correspondent - Analysis

European biotech hurting but lucky few to win big

LONDON (Reuters) - It promises to be a lousy year for many of Europe's cash-strapped biotechnology companies, but a lucky few stand to hit the jackpot in deals with 'Big Pharma'.

Select another date:

Press Releases

view news for: